238 related articles for article (PubMed ID: 34144926)
1. Visceral Obesity Promotes Lung Cancer Progression-Toward Resolution of the Obesity Paradox in Lung Cancer.
Barbi J; Patnaik SK; Pabla S; Zollo R; Smith RJ; Sass SN; Srinivasan A; Petrucci C; Seager R; Conroy J; Kannisto E; Wang X; Shah S; Gosain R; Attwood K; Roche C; Yendamuri S
J Thorac Oncol; 2021 Aug; 16(8):1333-1348. PubMed ID: 34144926
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Visceral Obesity in Non-Small Cell Lung Cancer.
Nitsche L; Vedire Y; Kannisto E; Wang X; Seager RJ; Pabla S; Patnaik SK; Yendamuri S
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884508
[TBL] [Abstract][Full Text] [Related]
4. Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer.
Vedire YR; Mukherjee S; Dondapati S; Yendamuri S
Sci Rep; 2023 May; 13(1):8401. PubMed ID: 37225730
[TBL] [Abstract][Full Text] [Related]
5. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.
Clark W; Siegel EM; Chen YA; Zhao X; Parsons CM; Hernandez JM; Weber J; Thareja S; Choi J; Shibata D
J Am Coll Surg; 2013 Jun; 216(6):1070-81. PubMed ID: 23523147
[TBL] [Abstract][Full Text] [Related]
6. Body Mass Index Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC.
Yendamuri S; Barbi J; Pabla S; Petrucci C; Punnanitinont A; Nesline M; Glenn ST; Depietro P; Papanicalou-Sengos A; Morrison C; Dy GK; Elkin PL
J Thorac Oncol; 2019 Dec; 14(12):2181-2187. PubMed ID: 31398539
[TBL] [Abstract][Full Text] [Related]
7. Higher visceral fat area/subcutaneous fat area ratio measured by computed tomography is associated with recurrence and poor survival in patients with mid and low rectal cancers.
Lee KH; Kang BK; Ahn BK
Int J Colorectal Dis; 2018 Sep; 33(9):1303-1307. PubMed ID: 29713823
[TBL] [Abstract][Full Text] [Related]
8. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis.
Delgado C; Chertow GM; Kaysen GA; Dalrymple LS; Kornak J; Grimes B; Johansen KL
Am J Kidney Dis; 2017 Dec; 70(6):817-825. PubMed ID: 28870376
[TBL] [Abstract][Full Text] [Related]
9. Visceral obesity is associated with lower stage colon tumors in males without survival advantage.
Silva A; Gomes F; Pereira SS; Monteiro MP; Araújo A; Faria G
Surg Oncol; 2021 Jun; 37():101606. PubMed ID: 34044270
[TBL] [Abstract][Full Text] [Related]
10. Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
Martini DJ; Kline MR; Liu Y; Shabto JM; Williams MA; Khan AI; Lewis C; Collins H; Akce M; Kissick HT; Carthon BC; Shaib WL; Alese OB; Pillai RN; Steuer CE; Wu CS; Lawson DH; Kudchadkar RR; El-Rayes BF; Ramalingam SS; Owonikoko TK; Harvey RD; Master VA; Bilen MA
Cancer; 2020 Feb; 126(3):575-582. PubMed ID: 31648379
[TBL] [Abstract][Full Text] [Related]
11. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
12. Elevated visceral obesity quantified by CT is associated with adverse postoperative outcome of laparoscopic radical nephrectomy for renal clear cell carcinoma patients.
Zhai T; Zhang B; Qu Z; Chen C
Int Urol Nephrol; 2018 May; 50(5):845-850. PubMed ID: 29611145
[TBL] [Abstract][Full Text] [Related]
13. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
[TBL] [Abstract][Full Text] [Related]
14. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
[TBL] [Abstract][Full Text] [Related]
15. Association of visceral obesity and early colorectal neoplasia.
Choe EK; Kim D; Kim HJ; Park KJ
World J Gastroenterol; 2013 Dec; 19(45):8349-56. PubMed ID: 24363527
[TBL] [Abstract][Full Text] [Related]
16. Visceral Fat and Anastomotic Leakage After Colon Cancer Resection.
Verduin WM; Warps AK; van den Helder R; Doodeman HJ; Houdijk APJ;
Dis Colon Rectum; 2021 Feb; 64(2):163-170. PubMed ID: 33394767
[TBL] [Abstract][Full Text] [Related]
17. Effect of Visceral Obesity on Surgical Outcomes of Patients Undergoing Laparoscopic Colorectal Surgery.
Park BK; Park JW; Ryoo SB; Jeong SY; Park KJ; Park JG
World J Surg; 2015 Sep; 39(9):2343-53. PubMed ID: 25917197
[TBL] [Abstract][Full Text] [Related]
18. Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer.
Kuritzkes BA; Pappou EP; Kiran RP; Baser O; Fan L; Guo X; Zhao B; Bentley-Hibbert S
Int J Colorectal Dis; 2018 Aug; 33(8):1019-1028. PubMed ID: 29658059
[TBL] [Abstract][Full Text] [Related]
19. Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy.
Ohwaki K; Endo F; Hattori K
Eur J Cancer; 2015 Mar; 51(5):604-9. PubMed ID: 25613441
[TBL] [Abstract][Full Text] [Related]
20. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
